Buddhachinaraj Hospital   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Phitsanulok Thailand (1940)

Organization Overview

First Clinical Trial
2011
NCT01307124
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Buddhachinaraj Hospital | Buddhachinnaraj Hospital | Infectious Disease Buddhachinaraj Phitsanulok Hospital

Active Ingredients

Drugs in Phase 3 Trials (3)

isoniazid (nydrazid) (1 trial)

lopinavir (Kaletra) (1 trial)

rifapentine (priftin) (1 trial)

Drugs in Phase 2 Trials (1)

dolutegravir (tivicay) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coinfection (Phase 2)

Communicable Diseases (Phase 3)

Infections (Phase 3)

Latent Tuberculosis (Phase 3)

Tuberculosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4